Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence G Lum

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 31, 2001
Immune Modulation in Cancer Patients After Adoptive Transfer of Anti-CD3/Anti-CD28-Costimulated T Cells-Phase I Clinical TrialLawrence G Lum, Ann V LeFever, Jonathan S Treisman, et al.
Cancer Immunology, Immunotherapy : CII|October 6, 2011
A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cellsArchana Thakur, Dana Schalk, Sanila H Sarkar, et al.
Pediatric Blood & Cancer|June 19, 2012
Anti-CD3 × anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targetsMaxim Yankelevich, Sri Vidya Kondadasula, Archana Thakur, et al.
Plos One|November 28, 2012
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cellsArchana Thakur, Lawrence G Lum, Dana Schalk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2012
Targeting cytomegalovirus-infected cells using T cells armed with anti-CD3 × anti-CMV bispecific antibodyLawrence G Lum, Mayur Ramesh, Archana Thakur, et al.
Journal of Translational Medicine|February 12, 2013
Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathwayArchana Thakur, Dana Schalk, Elyse Tomaszewski, et al.
Anticancer Research|April 9, 2005
Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomasHillary E Lum, Mendy Miller, Pamela A Davol, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2011
Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activitySagar Dandawate, Linford Williams, Nirmal Joshee, et al.
Frontiers in Immunology|July 22, 2021
Bispecific Antibody Armed Metabolically Enhanced Headless CAR T CellsArchana Thakur, John Scholler, Ewa Kubicka, et al.
Oncoimmunology|June 14, 2021
Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsivenessArchana Thakur, Johnson Ung, Elyse N Tomaszewski, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 31, 2001
Immune Modulation in Cancer Patients After Adoptive Transfer of Anti-CD3/Anti-CD28-Costimulated T Cells-Phase I Clinical TrialLawrence G Lum, Ann V LeFever, Jonathan S Treisman, et al.
Cancer Immunology, Immunotherapy : CII|October 6, 2011
A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cellsArchana Thakur, Dana Schalk, Sanila H Sarkar, et al.
Pediatric Blood & Cancer|June 19, 2012
Anti-CD3 × anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targetsMaxim Yankelevich, Sri Vidya Kondadasula, Archana Thakur, et al.
Plos One|November 28, 2012
Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cellsArchana Thakur, Lawrence G Lum, Dana Schalk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2012
Targeting cytomegalovirus-infected cells using T cells armed with anti-CD3 × anti-CMV bispecific antibodyLawrence G Lum, Mayur Ramesh, Archana Thakur, et al.
Journal of Translational Medicine|February 12, 2013
Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathwayArchana Thakur, Dana Schalk, Elyse Tomaszewski, et al.
Anticancer Research|April 9, 2005
Preclinical studies comparing different bispecific antibodies for redirecting T cell cytotoxicity to extracellular antigens on prostate carcinomasHillary E Lum, Mendy Miller, Pamela A Davol, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2011
Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activitySagar Dandawate, Linford Williams, Nirmal Joshee, et al.
Frontiers in Immunology|July 22, 2021
Bispecific Antibody Armed Metabolically Enhanced Headless CAR T CellsArchana Thakur, John Scholler, Ewa Kubicka, et al.
Oncoimmunology|June 14, 2021
Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsivenessArchana Thakur, Johnson Ung, Elyse N Tomaszewski, et al.
Pageof 9